Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus. / Rostgaard, Nina; Olsen, Markus Harboe; Lolansen, Sara Diana; Nørager, Nicolas Hernandez; Plomgaard, Peter; MacAulay, Nanna; Juhler, Marianne.

In: Acta Neurochirurgica, Vol. 165, 2023, p. 4059–4070.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rostgaard, N, Olsen, MH, Lolansen, SD, Nørager, NH, Plomgaard, P, MacAulay, N & Juhler, M 2023, 'Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus', Acta Neurochirurgica, vol. 165, pp. 4059–4070. https://doi.org/10.1007/s00701-023-05832-y

APA

Rostgaard, N., Olsen, M. H., Lolansen, S. D., Nørager, N. H., Plomgaard, P., MacAulay, N., & Juhler, M. (2023). Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus. Acta Neurochirurgica, 165, 4059–4070. https://doi.org/10.1007/s00701-023-05832-y

Vancouver

Rostgaard N, Olsen MH, Lolansen SD, Nørager NH, Plomgaard P, MacAulay N et al. Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus. Acta Neurochirurgica. 2023;165:4059–4070. https://doi.org/10.1007/s00701-023-05832-y

Author

Rostgaard, Nina ; Olsen, Markus Harboe ; Lolansen, Sara Diana ; Nørager, Nicolas Hernandez ; Plomgaard, Peter ; MacAulay, Nanna ; Juhler, Marianne. / Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus. In: Acta Neurochirurgica. 2023 ; Vol. 165. pp. 4059–4070.

Bibtex

@article{3a9591db61eb49e8bf18fdaa6441e520,
title = "Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus",
abstract = "Background: By applying an unbiased proteomic approach, we aimed to search for cerebrospinal fluid (CSF) protein biomarkers distinguishing between obstructive and communicating hydrocephalus in order to improve appropriate surgical selection for endoscopic third ventriculostomy vs. shunt implants. Our second study purpose was to look for potential CSF biomarkers distinguishing between patients with adult chronic hydrocephalus benefitting from surgery (responders) vs. those who did not (non-responders). Methods: Ventricular CSF samples were collected from 62 patients with communicating hydrocephalus and 28 patients with obstructive hydrocephalus. CSF was collected in relation to the patients{\textquoteright} surgical treatment. As a control group, CSF was collected from ten patients with unruptured aneurysm undergoing preventive surgery (vascular clipping). Results: Mass spectrometry-based proteomic analysis of the samples identified 1251 unique proteins. No proteins differed significantly between the communicating hydrocephalus group and the obstructive hydrocephalus group. Four proteins were found to be significantly less abundant in CSF from communicating hydrocephalus patients compared to control subjects. A PCA plot revealed similar proteomic CSF profiles of obstructive and communicating hydrocephalus and control samples. For obstructive hydrocephalus, ten proteins were found to predict responders from non-responders. Conclusion: Here, we show that the proteomic profile of ventricular CSF from patients with hydrocephalus differs slightly from control subjects. Furthermore, we find ten predictors of response to surgical outcome (endoscopic third ventriculostomy or ventriculo-peritoneal shunt) in patients with obstructive hydrocephalus.",
keywords = "Biomarkers, Cerebrospinal fluid, Idiopathic normal pressure hydrocephalus, Mass spectrometry, Obstructive hydrocephalus, Predictors, Proteomic profile, Proteomics",
author = "Nina Rostgaard and Olsen, {Markus Harboe} and Lolansen, {Sara Diana} and N{\o}rager, {Nicolas Hernandez} and Peter Plomgaard and Nanna MacAulay and Marianne Juhler",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
doi = "10.1007/s00701-023-05832-y",
language = "English",
volume = "165",
pages = "4059–4070",
journal = "Acta Neurochirurgica",
issn = "0001-6268",
publisher = "Springer Wien",

}

RIS

TY - JOUR

T1 - Ventricular CSF proteomic profiles and predictors of surgical treatment outcome in chronic hydrocephalus

AU - Rostgaard, Nina

AU - Olsen, Markus Harboe

AU - Lolansen, Sara Diana

AU - Nørager, Nicolas Hernandez

AU - Plomgaard, Peter

AU - MacAulay, Nanna

AU - Juhler, Marianne

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2023

Y1 - 2023

N2 - Background: By applying an unbiased proteomic approach, we aimed to search for cerebrospinal fluid (CSF) protein biomarkers distinguishing between obstructive and communicating hydrocephalus in order to improve appropriate surgical selection for endoscopic third ventriculostomy vs. shunt implants. Our second study purpose was to look for potential CSF biomarkers distinguishing between patients with adult chronic hydrocephalus benefitting from surgery (responders) vs. those who did not (non-responders). Methods: Ventricular CSF samples were collected from 62 patients with communicating hydrocephalus and 28 patients with obstructive hydrocephalus. CSF was collected in relation to the patients’ surgical treatment. As a control group, CSF was collected from ten patients with unruptured aneurysm undergoing preventive surgery (vascular clipping). Results: Mass spectrometry-based proteomic analysis of the samples identified 1251 unique proteins. No proteins differed significantly between the communicating hydrocephalus group and the obstructive hydrocephalus group. Four proteins were found to be significantly less abundant in CSF from communicating hydrocephalus patients compared to control subjects. A PCA plot revealed similar proteomic CSF profiles of obstructive and communicating hydrocephalus and control samples. For obstructive hydrocephalus, ten proteins were found to predict responders from non-responders. Conclusion: Here, we show that the proteomic profile of ventricular CSF from patients with hydrocephalus differs slightly from control subjects. Furthermore, we find ten predictors of response to surgical outcome (endoscopic third ventriculostomy or ventriculo-peritoneal shunt) in patients with obstructive hydrocephalus.

AB - Background: By applying an unbiased proteomic approach, we aimed to search for cerebrospinal fluid (CSF) protein biomarkers distinguishing between obstructive and communicating hydrocephalus in order to improve appropriate surgical selection for endoscopic third ventriculostomy vs. shunt implants. Our second study purpose was to look for potential CSF biomarkers distinguishing between patients with adult chronic hydrocephalus benefitting from surgery (responders) vs. those who did not (non-responders). Methods: Ventricular CSF samples were collected from 62 patients with communicating hydrocephalus and 28 patients with obstructive hydrocephalus. CSF was collected in relation to the patients’ surgical treatment. As a control group, CSF was collected from ten patients with unruptured aneurysm undergoing preventive surgery (vascular clipping). Results: Mass spectrometry-based proteomic analysis of the samples identified 1251 unique proteins. No proteins differed significantly between the communicating hydrocephalus group and the obstructive hydrocephalus group. Four proteins were found to be significantly less abundant in CSF from communicating hydrocephalus patients compared to control subjects. A PCA plot revealed similar proteomic CSF profiles of obstructive and communicating hydrocephalus and control samples. For obstructive hydrocephalus, ten proteins were found to predict responders from non-responders. Conclusion: Here, we show that the proteomic profile of ventricular CSF from patients with hydrocephalus differs slightly from control subjects. Furthermore, we find ten predictors of response to surgical outcome (endoscopic third ventriculostomy or ventriculo-peritoneal shunt) in patients with obstructive hydrocephalus.

KW - Biomarkers

KW - Cerebrospinal fluid

KW - Idiopathic normal pressure hydrocephalus

KW - Mass spectrometry

KW - Obstructive hydrocephalus

KW - Predictors

KW - Proteomic profile

KW - Proteomics

U2 - 10.1007/s00701-023-05832-y

DO - 10.1007/s00701-023-05832-y

M3 - Journal article

C2 - 37857909

AN - SCOPUS:85174513387

VL - 165

SP - 4059

EP - 4070

JO - Acta Neurochirurgica

JF - Acta Neurochirurgica

SN - 0001-6268

ER -

ID: 371932012